Literature DB >> 12799512

Optimizing blood culture practices in pediatric immunocompromised patients: evaluation of media types and blood culture volume.

Aditya H Gaur1, Mary Anne Giannini, Patricia M Flynn, Jan W Boudreaux, Mark A Mestemacher, Jerry L Shenep, Randall T Hayden.   

Abstract

BACKGROUND: The optimal use of blood cultures to determine the etiology of febrile episodes in neutropenic children has not been well-defined.
METHODS: Single volume blood cultures using the Pediatric ISOLATOR System (ISO), were compared with variable, weight-based culture volumes using the BACTEC 9240 Culture System (BAC). Additionally the value of routinely inoculating the BACTEC MYCO/F LYTIC culture vial (MFL) as well as the BACTEC AEROBIC/F culture vial (AF) was examined.
RESULTS: A total of 2620 cultures had both ISO and BAC inoculated; 182 cultures were positive (7.0% of cultures); 97.8% of positive cultures were detected by the BAC (AF and/or MFL) vs.46.2% detected by the ISO. The advantage of the BAC over the ISO was statistically significant for overall recovery of isolates and bloodstream infections, including most individual organism categories. There were only two instances (one each of histoplasmosis and candidemia) in which a blood stream infection was detected by ISO only. All the isolates judged to be contaminants were recovered by BAC only. AF detected significantly more coagulase-negative Staphylococcus spp. than the MFL. Of the isolates 16%, representing 14% of the bloodstream infections (including Gram-negative infections), were detected by the MFL only. Infections were detected more quickly by BAC than by ISO (P < 0.0001). Among the BAC media types, AF was faster than MFL (P < 0.0001).
CONCLUSIONS: Optimal yield of blood cultures in immunocompromised pediatric patients included the use of BAC with a weight-based, graduated volume of culture inoculation and routine use of both AF and MFL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799512     DOI: 10.1097/01.inf.0000069762.44241.0d

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

1.  DIAGNOSIS OF HISTOPLASMOSIS.

Authors:  Allan Jefferson Guimarães; Joshua D Nosanchuk; Rosely Maria Zancopé-Oliveira
Journal:  Braz J Microbiol       Date:  2006-01       Impact factor: 2.476

2.  Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.

Authors:  Hiroto Inaba; Aditya H Gaur; Xueyuan Cao; Patricia M Flynn; Stanley B Pounds; Viswatej Avutu; Lindsay N Marszal; Scott C Howard; Ching-Hon Pui; Raul C Ribeiro; Randall T Hayden; Jeffrey E Rubnitz
Journal:  Cancer       Date:  2014-03-26       Impact factor: 6.860

Review 3.  Optimum management of pediatric patients with fever and neutropenia.

Authors:  Aditya H Gaur; Patricia M Flynn; Jerry L Shenep
Journal:  Indian J Pediatr       Date:  2004-09       Impact factor: 1.967

4.  Repeating blood cultures in neutropenic children with persistent fevers when the initial blood culture is negative.

Authors:  Jeremy Rosenblum; Juan Lin; Mimi Kim; Adam S Levy
Journal:  Pediatr Blood Cancer       Date:  2012-10-09       Impact factor: 3.167

5.  Etiology and clinical course of febrile neutropenia in children with cancer.

Authors:  Hana Hakim; Patricia M Flynn; Katherine M Knapp; Deo Kumar Srivastava; Aditya H Gaur
Journal:  J Pediatr Hematol Oncol       Date:  2009-09       Impact factor: 1.289

6.  Noninvasive ventilation for patients near the end of life: what do we know and what do we need to know?

Authors:  William J Ehlenbach; J Randall Curtis
Journal:  Crit Care Med       Date:  2008-03       Impact factor: 7.598

Review 7.  Surveillance of bloodstream infections in pediatric cancer centers - what have we learned and how do we move on?

Authors:  Arne Simon; Rhoikos Furtwängler; Norbert Graf; Hans Jürgen Laws; Sebastian Voigt; Brar Piening; Christine Geffers; Philipp Agyeman; Roland A Ammann
Journal:  GMS Hyg Infect Control       Date:  2016-05-12

8.  Management of children with fever and neutropenia: results of a survey in 51 pediatric cancer centers in Germany, Austria, and Switzerland.

Authors:  Max Scheler; Thomas Lehrnbecher; Andreas H Groll; Ruth Volland; Hans-Jürgen Laws; Roland A Ammann; Philipp Agyeman; Andishe Attarbaschi; Margaux Lux; Arne Simon
Journal:  Infection       Date:  2020-06-10       Impact factor: 3.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.